# US 2025/0082205 A1 · Method and System for Enhanced Fluorescence Tissue and Cancer Margin Imaging

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0082205 A1
- Document ID: US20250082205A1
- Status: Published application
- Kind: A1
- Application number: 18/882,678
- Filed: 2024-09-11
- Published: 2025-03-13
- Earliest claimed: 2023-09-11
- Assignees: CytoVeris, Inc.
- Applicants: CytoVeris Inc.
- Inventors: Alan Kersey; Rishikesh Pandey
- Web page: https://patentgrep.com/patent/US20250082205A1

## CPC

- A61B 5/0071: {by measuring fluorescence emission}
- A61B 2505/05: Surgical care
- A61B 2576/00: Medical imaging apparatus involving image processing or analysis (A61B1/00009, A61B6/52 and A61B8/52 take precedence)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A method and system for analyzing a tissue, the method includes: administering a fluorescent agent to the tissue; producing a first excitation light configured to produce an autofluorescence emission from a biomolecule present within the tissue, and a diffuse reflectance signal from the tissue; producing a second excitation light configured to produce a fluorescence emission from the fluorescent agent administered to the tissue; using a photodetector to detect the autofluorescence emissions, the diffuse reflectance signals and produce first signals representative of the autofluorescence emission and the diffuse reflectance; using the photodetector to detect the fluorescence emissions and produce second signals representative of the fluorescence emission; producing a first image using the first signals; producing a second image using the second signals; and analyzing the tissue using the first image and the second image to identify the presence of diseased tissue within the tissue.

## Claims

### Claim 1

A system for analyzing a tissue, comprising:
an excitation light unit configured to selectively produce a plurality of excitation lights, each said excitation light centered on a wavelength distinct from the centered wavelength of the other said excitation lights, wherein the plurality of excitation lights includes a plurality of first excitation lights configured to produce an autofluorescence emission from one or more biomolecules of interest present within the tissue, and a diffuse reflectance signal from the tissue, and a second excitation light is configured to produce a fluorescence emission from a fluorescent agent administered to the tissue;
a photodetector configured to detect the autofluorescence emission and the diffuse reflectance resulting from the plurality of first excitation lights directed to the tissue and produce first signals representative of the autofluorescence emission and the diffuse reflectance, and configured to detect the fluorescence emission signal resulting from the second excitation light directed to the tissue and produce second signals representative of the fluorescence emission; and
a system controller in communication with the excitation light unit, the photodetector, and a non-transitory memory storing instructions, which instructions when executed cause the system controller to:
control the excitation light unit to sequentially produce the first excitation light and the second excitation light;
receive and process the first signals to produce a first image representative of the first signals, and receive and process the second signals to produce a second image representative of the second signals; and
analyze the tissue using the first image and the second image to identify the presence of diseased tissue within the tissue.

### Claim 2 (depends on 1)

The system of claim 1, wherein the first signals representative of the autofluorescence emission and the diffuse reflectance are used to create a map of tissue type in the imaged tissue, and this map is used to correct optical inaccuracies in the second signals representative of the fluorescence emission.

### Claim 3

A method of analyzing a tissue, comprising:
administering a fluorescent agent to the tissue;
producing a first excitation light centered on a first wavelength, wherein the first excitation light is configured to produce an autofluorescence emission from one or more biomolecules of interest present within the tissue, and a diffuse reflectance signal from the tissue;
producing a second excitation light centered on a second wavelength, wherein the second excitation light is configured to produce a fluorescence emission from the fluorescent agent administered to the tissue;
using a photodetector to detect the autofluorescence emissions, the diffuse reflectance signals and produce first signals representative of the autofluorescence emission and the diffuse reflectance;
using the photodetector to detect the fluorescence emissions and produce second signals representative of the fluorescence emission;
producing a first image using the first signals;
producing a second image using the second signals; and
analyzing the tissue using the first image and the second image to identify the presence of diseased tissue within the tissue.
